Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's

Inclusion Criteria

• •Have had a diagnosis of probable Alzheimer's disease.
• •Men or women ages 55 years or greater and living in the community at the time of enrollment (i.e., not living in a rest home or nursing care facility).
• •Signed the subject Informed Consent Form and is willing and able to participate for the duration of the study.
• •Ability to read and understand English or Spanish to ensure compliance with cognitive testing and study visit procedures.
• •Female subjects must be surgically sterile or postmenopausal for \> 1 year.
• •Subjects currently taking approved medication for Alzheimer's disease for at least six months prior to day 1 may be enrolled.
• •Subjects must have a reliable caregiver who can read, understand and speak English or Spanish.